Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial-Reference-Cited by-同舟云学术

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Published:2016-11 Issue:3 Volume:1 Page:185-195
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Chan Henry L Y,Fung Scott,Seto Wai Kay,Chuang Wan-Long,Chen Chi-Yi,Kim Hyung Joon,Hui Aric Josun,Janssen Harry L A,Chowdhury Abhijit,Tsang Tak Yin Owen,Mehta Rajiv,Gane Edward,Flaherty John F,Massetto Benedetta,Gaggar Anuj,Kitrinos Kathryn M,Lin Lanjia,Subramanian G Mani,McHutchison John G,Lim Young-Suk,Acharya Subrat K,Agarwal Kosh

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference39 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. Chronic hepatitis B infection;Kuo;Clin Liver Dis,2012

3. Chronic hepatitis B virus infection;McMahon;Med Clin North Am,2014

4. Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities;Gish;Antivir Res,2015

5. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010;Lozano;Lancet,2012

Cited by 345 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focal coagulative necrosis of the liver in a patient with sustained virologic response to anti-hepatitis C virus therapy;Radiology Case Reports;2024-04

2. Managing HBV and HCV Infection Pre- and Post-liver Transplant;Journal of Clinical and Experimental Hepatology;2024-03

3. Cost–effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece;Journal of Comparative Effectiveness Research;2024-02-06

4. Real‐world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis B;Journal of Viral Hepatitis;2024-01

5. Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses;JHEP Reports;2024-01